To Evaluate the Safety and Effectiveness of Atorvastatin Plus a Cholinesterase Inhibitor in AD Patients.
NCT ID: NCT00151502
Last Updated: 2021-02-18
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
PHASE3
600 participants
INTERVENTIONAL
2002-11-30
2007-07-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of ABT-957 in Subjects With Mild-to-Moderate Alzheimer's Disease on Stable Doses of Acetylcholinesterase Inhibitors
NCT02220738
Lipitor as a Treatment for Alzheimer's Disease
NCT00024531
Safety, Tolerability, and Pharmacokinetics of ABT-354 in Subjects With Mild-to-Moderate Alzheimer's Disease on Stable Doses of Acetylcholinesterase Inhibitors
NCT01908010
A Study on the Safety, Tolerability and Immunogenicity of ALZ-101 in Participants With Early Alzheimer's Disease
NCT05328115
Evaluate the Efficacy and Safety of ABT-126 in Subjects With Mild to Moderate Alzheimer's Disease on Stable Doses of Acetylcholinesterase Inhibitors
NCT01549834
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
DOUBLE
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Atorvastatin
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Subject's Mini-Mental Status Examination Score (MMSE) must be in the range of 13 - 25 (inclusive) at Screening.
Exclusion Criteria
* Any condition, which, in the investigator's judgment might increase the risk to the subject or decrease the reliability of the data required to meet the objectives of the study.
50 Years
90 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Pfizer's Upjohn has merged with Mylan to form Viatris Inc.
INDUSTRY
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Pfizer CT.gov Call Center
Role: STUDY_DIRECTOR
Pfizer
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Pfizer Investigational Site
Sun City, Arizona, United States
Pfizer Investigational Site
Fresno, California, United States
Pfizer Investigational Site
Laguna Hills, California, United States
Pfizer Investigational Site
San Francisco, California, United States
Pfizer Investigational Site
Fort Lauderdale, Florida, United States
Pfizer Investigational Site
Fort Myers, Florida, United States
Pfizer Investigational Site
Miami Beach, Florida, United States
Pfizer Investigational Site
Pompano Beach, Florida, United States
Pfizer Investigational Site
St. Petersburg, Florida, United States
Pfizer Investigational Site
West Palm Beach, Florida, United States
Pfizer Investigational Site
Fort Wayne, Indiana, United States
Pfizer Investigational Site
Paducah, Kentucky, United States
Pfizer Investigational Site
New Orleans, Louisiana, United States
Pfizer Investigational Site
South Dartmouth, Massachusetts, United States
Pfizer Investigational Site
West Yarmouth, Massachusetts, United States
Pfizer Investigational Site
Worcester, Massachusetts, United States
Pfizer Investigational Site
Kalamazoo, Michigan, United States
Pfizer Investigational Site
Jamesburg, New Jersey, United States
Pfizer Investigational Site
Princeton, New Jersey, United States
Pfizer Investigational Site
Albuquerque, New Mexico, United States
Pfizer Investigational Site
Albany, New York, United States
Pfizer Investigational Site
Rochester, New York, United States
Pfizer Investigational Site
Troy, New York, United States
Pfizer Investigational Site
Tulsa, Oklahoma, United States
Pfizer Investigational Site
Allentown, Pennsylvania, United States
Pfizer Investigational Site
Allentown, Pennsylvania, United States
Pfizer Investigational Site
Jenkintown, Pennsylvania, United States
Pfizer Investigational Site
Pittsburgh, Pennsylvania, United States
Pfizer Investigational Site
Pittsburgh, Pennsylvania, United States
Pfizer Investigational Site
East Providence, Rhode Island, United States
Pfizer Investigational Site
Providence, Rhode Island, United States
Pfizer Investigational Site
Madison, Tennessee, United States
Pfizer Investigational Site
Austin, Texas, United States
Pfizer Investigational Site
Dallas, Texas, United States
Pfizer Investigational Site
Houston, Texas, United States
Pfizer Investigational Site
Wichita Falls, Texas, United States
Pfizer Investigational Site
Richmond, Virginia, United States
Pfizer Investigational Site
Seattle, Washington, United States
Pfizer Investigational Site
Madison, Wisconsin, United States
Pfizer Investigational Site
Milwaukee, Wisconsin, United States
Pfizer Investigational Site
East Gosford, New South Wales, Australia
Pfizer Investigational Site
Randwick, New South Wales, Australia
Pfizer Investigational Site
Daw Park, South Australia, Australia
Pfizer Investigational Site
Woodville South, South Australia, Australia
Pfizer Investigational Site
Ballarat, Victoria, Australia
Pfizer Investigational Site
WEST Heidelberg, Victoria, Australia
Pfizer Investigational Site
Nedlands, Western Australia, Australia
Pfizer Investigational Site
Vienna, , Austria
Pfizer Investigational Site
Vienna, , Austria
Pfizer Investigational Site
Wein, , Austria
Pfizer Investigational Site
Calgary, Alberta, Canada
Pfizer Investigational Site
Vancouver, British Columbia, Canada
Pfizer Investigational Site
Halifax, Nova Scotia, Canada
Pfizer Investigational Site
London, Ontario, Canada
Pfizer Investigational Site
Toronto, Ontario, Canada
Pfizer Investigational Site
Montreal, Quebec, Canada
Pfizer Investigational Site
Montreal, Quebec, Canada
Pfizer Investigational Site
Québec, Quebec, Canada
Pfizer Investigational Site
Verdun, Quebec, Canada
Pfizer Investigational Site
Aarhus, , Denmark
Pfizer Investigational Site
Copenhagen, , Denmark
Pfizer Investigational Site
Hillerød, , Denmark
Pfizer Investigational Site
Rudkøbing, , Denmark
Pfizer Investigational Site
Svendborg, , Denmark
Pfizer Investigational Site
Bad Honnef, , Germany
Pfizer Investigational Site
Berlin, , Germany
Pfizer Investigational Site
Bochum, , Germany
Pfizer Investigational Site
Bonn, , Germany
Pfizer Investigational Site
Göttingen, , Germany
Pfizer Investigational Site
Hanover, , Germany
Pfizer Investigational Site
München, , Germany
Pfizer Investigational Site
München, , Germany
Pfizer Investigational Site
Tübingen, , Germany
Pfizer Investigational Site
Rosebank, Gauteng, South Africa
Pfizer Investigational Site
Willows, Gauteng, South Africa
Pfizer Investigational Site
Pinetown, KwaZulu-Natal, South Africa
Pfizer Investigational Site
Belleville, , South Africa
Pfizer Investigational Site
Westville, , South Africa
Pfizer Investigational Site
Terrassa, Barcelona, Spain
Pfizer Investigational Site
Barcelona, , Spain
Pfizer Investigational Site
Barcelona, , Spain
Pfizer Investigational Site
Barcelona, , Spain
Pfizer Investigational Site
Madrid, , Spain
Pfizer Investigational Site
Madrid, , Spain
Pfizer Investigational Site
Linköping, , Sweden
Pfizer Investigational Site
Malmo, , Sweden
Pfizer Investigational Site
Mölndal, , Sweden
Pfizer Investigational Site
Stockholm, , Sweden
Pfizer Investigational Site
Uddevalla, , Sweden
Pfizer Investigational Site
Bradford, England, United Kingdom
Pfizer Investigational Site
Stirling, Stirlingshire, United Kingdom
Pfizer Investigational Site
Swindon, Wiltshire, United Kingdom
Pfizer Investigational Site
Bath, , United Kingdom
Pfizer Investigational Site
Belfast, , United Kingdom
Pfizer Investigational Site
Glasgow, , United Kingdom
Pfizer Investigational Site
Glasgow, , United Kingdom
Pfizer Investigational Site
Penarth, , United Kingdom
Pfizer Investigational Site
Southhampton, , United Kingdom
Pfizer Investigational Site
Stirling, , United Kingdom
Countries
Review the countries where the study has at least one active or historical site.
Related Links
Access external resources that provide additional context or updates about the study.
To obtain contact information for a study center near you, click here.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
A2581078
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.